Help Moms During Pregnancy
Volunteer for research to improve the health of moms and babies.
MotherToBaby is currently enrolling pregnant women in an observational study to explore how rheumatoid arthritis (RA), psoriasis (PSO), psoriatic arthritis (PsA), inflammatory bowel disease (IBD) & ankylosing spondylitis (AS), and its treatment affect pregnancy. All studies are conducted through phone interviews—no changes to your normal routine or travel required. If you’ve taken CIMZIA® (vedolizumab) and are pregnant, you may qualify for this important study.
MotherToBaby is the most trusted information source for medication safety in pregnancy.
“There is a huge need to generate more data for all of the drugs that pregnant women need to take.”
— Christina Chambers, PhD, MPH, MotherToBaby Pregnancy Studies
Make an impact on chronic illness research by enrolling into our pregnancy studies.
Join our CIMZIA® Study
Your information is confidential.
MotherToBaby Pregnancy Studies are conducted by the Organization of Teratology Information Specialists (OTIS) and coordinated by the University of California San Diego. MotherToBaby is listed as a resource for information about medications in pregnancy by the US Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC).
Questions? Call 866.626.6847 | Text 855.999.3525 | Email or Chat at MotherToBaby.org.
Disclaimer: MotherToBaby Fact Sheets are meant for general information purposes and should not replace the advice of your health care provider. MotherToBaby is a service of the non-profit Organization of Teratology Information Specialists (OTIS). OTIS/MotherToBaby recognizes that not all people identify as “men” or “women.” When using the term “mother,” we mean the source of the egg and/or uterus and by “father,” we mean the source of the sperm, regardless of the person’s gender identity. Copyright by OTIS, August 30, 2018.